Oct 26, 2022 / 01:00PM GMT
Operator
Good day, and welcome to the bioMérieux Q3 sales release conference call. Today's conference is being recorded. At this time, I would like to turn the conference over to Mr. Admant. Please go ahead, sir.
Franck Admant - bioMérieux S.A.-Director of IR
Thank you. Good afternoon, and thank you for joining us to review bioMérieux performance of its third quarter of 2022. As usual, I am online with Alexandre Merieux, Chairman and CEO; as well as Guillaume Bouhours, CFO. Before handing the call over to Alex Merieux for preliminary remarks, please note that this conference call will include forward-looking statements. I would like to remind you of the usual disclaimer stating that forward-looking statements are based entirely or partially on assessments of regimens that may change or be modified due to uncertainties and risks related to the company's environment, notably those described in the 2021 registration documents, including but not limited to economic conditions, financial exposures, currency exchange fluctuations, change in
Q3 2022 Biomerieux SA Corporate Sales Call Transcript
Feb 12, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers